Company Overview
American HealthCare Capital is pleased to exclusively present an opportunity to purchase a product line of state-of-the-art Spinal Implants from a medical device company. The Company has decided to focus its attention on an alternative metal alloy implant product and would like to divest this Spinal Implant product line.
The product line has 3 lines of business which includes:
- Modular Pedicle Screw (MPS) System
- Anterior Lumbar Interbody Fusion Cages (ALIF)
- Transforaminal / Posterior Lumbar Fusion Cages (TPLIF)
Financial Overview
The inventory value for these 3 lines of business is $459,000 for Implants and $365,000 for instruments, which comes to a total Inventory of $824,000. The implant product line consists of 4 FDA approvals: for PLIF Cage, Cervical Plate, Modular Pedicle Screw (MPS) System and Interbody Cages. Also, part of this transaction is a US Patent which covers the MPS product line.
These Spinal Implant product lines continue to be revenue-producing with $753,000 of Revenue in 2022 and $330,000 of revenue in 2023.
Asking Price
The company is selling its Spinal Implant devices and related Instruments with an inventory value of $824,000 plus 4 implant portfolio FDA Approvals, as well as the US Patent covering the MPS Product line.
The seller will consider competitive offers.
